Abbott Laboratories ABT Cash Flow Statement (2009-2026)

NYSE ABT
$105.82 +0.30 (+0.28%)
As of: Sep 9, 2026 · 12:14 PM EDT
Reported Financials

Abbott Laboratories Quarterly Cash Flow Statement

Periods 69 quarters
Latest Jun 2026

Abbott Laboratories reported cash from operations of $2.49B and free cash flow of $1.99B for the quarter ended Jun 2026, up 21.5% year over year. This cash flow statement covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
2.10B1.99B2.45B2.02B1.44B1.03B1.32B1.38B1.44B1.59B1.23B1.30B1.65B9.23B1.32B1.78B1.64B1.78B1.08B0.93B
Depreciation and DepletionDep. & Depletion
Share-based CompensationStock Comp.
0.55B0.11B0.30B0.14B0.12B0.12B0.28B0.13B0.12B0.11B0.30B0.14B0.12B0.11B0.29B0.14B0.12B0.11B0.32B0.17B
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
Cash from OperationsCash from Ops.
2.70B3.07B2.06B2.41B2.78B2.33B1.14B1.20B1.88B3.04B1.02B1.96B2.71B2.87B1.42B2.05B2.79B3.31B1.31B2.49B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in ReceivablesChange Receivables
0.39B0.19B0.75B0.19B-0.53B-0.34B-0.23B0.20B0.46B-0.07B0.15B0.33B0.06B0.16B0.26B0.41B0.20B-0.22B0.04B0.39B
Change in InventoryChange Inventory
-0.07B-0.01B0.55B0.48B0.19B0.19B0.42B0.25B-0.14B-0.29B0.41B0.10B-0.22B-0.23B0.26B-0.00B-0.21B-0.23B0.42B0.30B
Other Working Capital ChangesOther WC Changes
0.04B0.20B-0.09B-0.07B1.08B0.66B0.18B0.75B-0.14B0.02B0.44B0.24B-0.22B0.42B-1.02B
Investing Activities
Capital ExpendituresCapex
0.46B0.61B0.32B0.38B0.47B0.61B0.38B0.51B0.56B0.76B0.40B0.53B0.56B0.72B0.48B0.50B0.50B0.69B0.40B0.50B
Acquisitions
Divestments
0.09B
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
-0.65B-0.67B-0.36B-0.26B-0.48B-0.63B-0.46B-1.21B-0.63B-0.82B-0.42B-0.45B-0.59B-0.87B-0.47B-0.58B-0.46B-0.91B-20.32B-0.67B
Financing Activities
Other financing activitiesOther financing
0.07B0.08B0.06B0.01B0.06B0.04B0.06B0.01B0.06B0.03B0.13B0.01B0.09B0.03B0.29B0.04B0.07B0.01B0.12B0.00B
Cash from Financing ActivitiesCash from Financing
-1.38B-1.89B-3.82B-0.81B-1.54B-1.46B-1.41B-1.29B-2.34B-2.05B-1.18B-0.79B-1.58B-1.86B-2.06B-1.10B-1.76B-1.40B17.31B-3.52B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.00B0.00B
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.80B0.80B0.83B0.83B0.83B0.82B0.89B0.89B0.89B0.89B0.96B0.96B0.96B0.96B1.03B1.03B1.03B1.03B1.10B1.10B
Additional items
Exchange Rate EffectFX Effect
-0.03B-0.01B-0.01B-0.07B-0.10B0.05B0.01B-0.03B-0.03B0.03B-0.04B-0.01B0.04B-0.08B0.02B0.05B-0.01B0.01B-0.02B0.00B
Change in Cash
0.64B0.50B-2.12B1.26B0.66B0.29B-0.72B-1.33B-1.13B0.19B-0.61B0.70B0.57B0.06B-1.08B0.42B0.56B1.01B-1.72B-1.70B
Free Cash FlowFCF
2.24B2.45B1.74B2.03B2.31B1.72B0.76B0.70B1.32B2.28B0.63B1.43B2.15B2.15B0.93B1.54B2.29B2.63B0.92B1.99B
Net Cash FlowNCF
0.67B0.51B-2.12B1.33B0.75B0.24B-0.73B-1.30B-1.10B0.16B-0.58B0.72B0.54B0.14B-1.11B0.37B0.57B1.00B-1.70B-1.70B